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Abstract
Fasciola hepatica is a helminth parasite that causes fascioliasis in domestic ruminants 
and humans. Economic losses due to its infection are estimated in US$ 2000–3000 
million yearly [1]. The anthelmintics are at present the only weapon against these 
parasitic helminths [2]. The parasite resistance to different anthelmintics including 
that of F. hepatica to triclabendazole (TCBZ) is growing worldwide. Glutathione S‐
transferases (GSTs) are enzymes involved in the detoxification of a wide range of sub‐
strates through chemical conjugation with glutathione, so that the product becomes 
more soluble in water, less toxic and easier to excrete. Eight GST isoenzymes are 
present in F. hepatica [3]. Since the different isoenzymes do not necessarily have the 
same metabolic activity, in the present work, we evaluated the metabolic activity of 
total cytosolic GST and GST mu and GST pi isoenzymes in adult strains of F. hepatica 
susceptible (Cullompton) and resistant (Sligo and Oberon) to TCBZ of the highest meta‐
bolic activity of total GST. The genetic sequence database at the National Center for 
Biotechnical Information (NCBI) (GenBank ID: KF680281–KF680282) corresponding 
to the GST mu gene isolated from Cullompton strain (TCBZ‐susceptible) and (GenBank 
ID: KF680283–KF680284) corresponding to the GST mu gene isolated from Sligo strain 
(TCBZ‐resistant) in F. hepatica. Comparative analysis of both strains, Cullompton and 
Sligo, showed two nucleotide changes and change of one amino acid in the GST mu 
isoenzyme of the TCBZ‐resistant strain. These results together with the higher enzy‐
matic activity of GST have a potential relevance as it contribute to the understanding 
the mechanisms that generate resistance to anthelmintics and the activity, metabo‐
lism, and disposition of these drugs in the parasite.
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1. Introduction
Fasciola hepatica is a helminth parasite that causes fascioliasis in domestic ruminants and 
humans. Economic losses due to its infection are estimated in U$S 2000–3000 million yearly 
[1]. The anthelmintics are at present the only weapon against these parasitic helminths [2]. 
The parasite resistance to different anthelmintics including that of F. hepatica to triclabenda‐
zole (TCBZ) is growing worldwide [3]. In the last few years, a rise in cattle fasciolosis cases 
has been reported, probably due to weather changes determining a different distribution of 
the snail Galba truncatula, which is a required intermediate host [4]. Helminth parasites pos‐
sess different biochemical mechanisms for detoxification. Overall, parasites may evade drug 
antiparasitic effects by: (i) mutation of target receptors, (ii) overexpression of efflux transport 
pumps, and/or (iii) overexpression of metabolic enzymatic systems [5].
In fasciolosis, anthelmintic control is based mainly on the use of TCBZ, a halogenated benz‐
imidazole thiol derivative that shows excellent efficacy against both juvenile (immature) 
and adult stages. The nematodicidal action of benzimidazoles (BZDs) is based on their 
binding to beta‐Tubulin, which produces subsequent disruption of the tubulin‐microtu‐
bule dynamic equilibrium [6]. When the in vivo effect of TCBZ on the distribution of alpha 
and beta‐Tubulin was evaluated in the testis tubules of F. hepatica obtained from bovines 
exposed to this drug, the results obtained confirmed that TCBZ alters the distribution of the 
microtubules and reaffirmed that this is one of its main mechanisms of action [7, 8]. TCBZ 
is metabolized into its anthelmintically active metabolite sulphoxide (TCBZ‐SO) by the host 
liver [9] but also by the parasite’s subcellular fractions [10]. It has also been reported that F. 
hepatica has significantly higher sulphoxidation activity than nematode and cestode parasites 
[10]. The resistance to (BZDs) detected in other helminths such as Haemonchus contortus [11]. 
Although the flukicidal activity of TCBZ remains to be fully understood, there are data to 
support a microtubule‐based action of this compound. However, it has been shown that the 
TCBZ‐resistant F. hepatica is not associated with residue changes in the primary amino acid 
sequence of beta‐Tubulin [11]. This suggests that there may be an alternative mechanism of 
TCBZ resistance in F. hepatica [5].
The development of drug resistance can be facilitated by the action of xenobiotic metabolizing 
enzymes (XMEs) of phase I and phase II of detoxification [12]. In all organisms, XMEs serve 
as an efficient defense against the potential negative action of xenobiotics. Several phase I 
enzymes are expressed in mammalians, where they introduce or unmask new functionalities 
on xenobiotic compounds. Examples of these enzymes include cytochrome P450s (Cyt P450), 
flavin‐containing monooxygenases (FMO), alcohol and aldehyde dehydrogenases, and ester‐
ases. To eliminate a large array of chemicals, living organisms have developed, in virtually 
all tissue enzyme systems, XMEs that transform exogenous and endogenous compounds into 
more hydrophilic derivatives through reactions collectively known as biotransformation. At 
present, much less is known about the activity of certain phase II enzymes and relatively less 
attention has been paid to hydrolytic and conjugative pathways. Many phase II reactions in 
mammals involve conjugating potentially toxic substances to glutathione. These reactions are 
mediated by the enzyme glutathione S‐transferase (GST) enzymes [13]. Recent research has 
highlighted the importance of these transferases in the establishment of chronic helminth 
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infections. These proteins appear to be the main phase II detoxification system present in 
parasitic worms. General biological roles of helminth GSTs include xenobiotic detoxification 
and ligand binding/transport functions [14].
As many as eight GST isoforms have been shown to be present in F. hepatica [15]. The genes 
encoding the mu class of enzymes are organized in a gene cluster on 45 chromosome 1p13.3 
and are known to be highly polymorphic. The ability of helminth GSTs to effectively neutral‐
ize known cytotoxic products arising from the attack of reactive oxygen species on cell mem‐
branes provides evidence that GSTs have the potential to protect the parasite against different 
xenobiotics. In F. hepatica, GSTs are found in the tegument, muscular tissues, parenchymal 
cells, and the intestine [16]. GSTs account for as much as 4% of the total soluble protein [17] 
and are major detoxification enzymes in adult helminths, as these organisms appear to lack 
the important Cyt P450‐dependent detoxification reactions [18]. Results obtained in our labo‐
ratory confirmed that Cyt P450 are not only involved in detoxification mechanisms but also 
actively participate in the development of resistance to TCBZ by the trematode [19]. GSTs 
have been investigated in parasitic worms with respect to their biochemistry and have also 
been identified as potential vaccine candidates in digenean parasite. This property has been 
exploited with cGSTs [20–22]. Most studies concerning the metabolic response of F. hepatica 
against the anthelmintic TCBZ have used in vitro or ex vivo test models [23].
Whereas the background about the interactions with such enzymatic systems may drastically 
affect the disposition kinetics of different drugs [24], the aim of the present work was to evalu‐
ate in vitro of total cGST and cGSTmu and cGSTpi isoenzymes in the susceptible (Cullompton) 
and resistant (Sligo and Oberon) strains of F. hepatica and identified and characterized the gene 
GST mu isolated isolate from Cullompton strain (TCBZ‐susceptible) and Sligo (TCBZ‐resistant) in 
F. hepatica.
2. Materials and methods
2.1. Collection of parasite material
Nine (9) parasite‐free Corriedale weaned lambs were orally infected each with 200 metacer‐
cariae of F. hepatica.
2.2. Collection and processing of adult flukes
Adult flukes were collected from bile ducts and liver and processed. The collection of the 
flukes, their processing to obtain the cytosolic [25].
2.3. Preparation of cytosolic fractions
Parasite specimens (10–15 g) of the TCBZ‐susceptible or TCBZ‐resistant isolates of F. hepatica were 
rinsed with cold KCl (1.15%) and then transported to the laboratory in flasks filled with phosphate 
buffer (PB) (0.1 M, pH 7.4) at 4°C. All subsequent operations were performed between 0 and 4°C. 
Each sample was cut into small pieces and washed several times with PB. Samples were homogenized 
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(1:1) in PB, pH 7.4 with an Ultra‐Turrax homogenizer (IKA Works Inc., Wilmington, USA), centri‐
fuged at 10,000 g for 20 min and the resulting supernatant centrifuged at 100,000 g for 60 min.
The supernatant was collected and stored at −80°C until the analysis. Protein content from the 
supernatant fractions was determined using bovine serum albumin as a standard [26].
Total cGST activity using 1‐chloro, 2,4‐dinitrobenzene as substrate (CDNB), GST‐pi activity using 
ethacrynic acid as substrate and GST mu activity using 3,4‐dichloronitrobenzene (DCNB) as 
substrate were monitored by a continuous spectrophotometric method [27].
2.4. Reverse transcription polymerase chain reaction (RT‐PCR)
Total RNA was isolated from each strain of adult trematodes (n = 15) using Trizol, and reverse 
transcribed using superscript III RNAase® (Applied Biosystems, Brunn am Gebirge, Austria) 
following the protocol recommended by the manufacturers [28].
2.5. PCR amplification of cDNA
The PCR product was analyzed by electrophoresis in 1% agarose gel.
3. Results
Total GST activity (n = 13) in each strains was different in all strains tested. In the Sligo (1277 
± 32 nmol/min/mg protein) and Oberon (1216 ± 16 nmol/min/mg protein), strains were 59 
and 52%, respectively, higher (P < 0.001) than in the susceptible Cullompton strain (800 ± 60 
nmol/min/mg protein) (Figure 1). GST mu activity in Oberon (1.37 nmol/min/mg protein) 
Figure 1. Quantification of total activity of glutathione S‐transferase (GST) in Fasciola hepatica susceptible (Cullompton 
strain) and resistant (Sligo and Oberon strains) to triclabendazole.
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and Sligo (1.28 nmol/min/mg protein) resistant strains was 17 and 26%, respectively, higher 
than in the susceptible Cullompton strain (0.8 nmol/min/mg protein) (Figure 2) while GST‐
pi activity did not differ between the different strains tested (Figure 3). RT‐PCR (Figure 4). 
The genetic sequence database at the National Center for Biotechnical Information (NCBI) 
(GenBank ID: KF680281–KF680282) corresponding to the GST mu gene isolated from the 
Cullompton strain (TCBZ‐susceptible) and (GenBank ID:KF680283–KF680284) to the GST 
Figure 2. Quantification of activity of mu glutathione S‐transferase (GST) in Fasciola hepatica susceptible (Cullompton 
strain) and resistant (Sligo and Oberon strains) to triclabendazole.
Figure 3. Quantification of activity of pi glutathione S‐transferase (GST) in Fasciola hepatica susceptible (Cullompton strain) 
and resistant (Sligo and Oberon strains) to triclabendazole.
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mu gene isolated from the Sligo strain (TCBZ‐resistant) in F. hepatica (Figures 5 and 6) can 
be substituted by other polar or small amino acids in particular threonine which differs 
only in that it has a methyl group in place of a hydrogen group found in serine. Serines are 
quite common in protein functional centers.
4. Discussion
In the absence of an efficacious vaccine, chemotherapy remains the main tool in treating fas‐
ciolosis. Although other alternatives exist, current measures to control fasciolosis are based on 
the use of drugs such as triclabendazole (TCBZ) [29, 30].
In the anthelmintics, has been adults [9, 29, 31].
Parasite defense mechanisms include detoxifying and anti‐oxidant enzymes that would suppress its 
oxidative killing [23]. Therefore, it is necessary to know the mechanisms of detoxification and mecha‐
nism of anthelmintic resistance of F. hepatica.
Other possibilities include enhanced substrate affinity of the enzymes brought about by 
mutations within their encoding genes. Residue changes may also influence the substrate 
specificity of the enzymes and could explain why TCBZ‐resistant flukes remain susceptible 
to ABZ [14, 32–35].
Figure 4. A 657‐bp band compatible with the expected size in the 100‐bp DNA ladder marker (lane 1), Cullompton strain 
(lane 2), and Sligo (lane 3) was obtained.
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Figure 5. CLUSTAL 2.1 multiple sequence alignment.
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GSTs are regulated by a structurally diverse range of xenobiotics, and at least 100 chemicals 
have been identified to induce GSTs. Many of the compounds that induce GSTs are them‐
selves substrates for these enzymes or are metabolized (by CytP450 or FMO) to compounds 
that can serve as GST substrates, suggesting that GST induction represents part of an adaptive 
response mechanism to chemical stress caused by electrophiles [36].
In the present work, cGST was analyzed in three strains of F. hepatica (Cullompton, a 
TCBZ‐susceptible strain, and Sligo and Oberon, TCBZ‐resistant strains).
The activity of Sligo and Oberon strains expressed significantly higher metabolic activity 
than that measured in the cytosolic fractions obtained from the susceptible strain. In this 
work identified and characterized the GST mu gene isolated from TCBZ‐susceptible and 
TCBZ‐resistant F. hepatica strains, and comparative analysis of both strains Cullompton and 
Sligo showed change two nucleotide and changes GST mu protein: Threonine in the TCBZ‐ 
susceptible strain by Serine in the TCBZ‐resistant strain can be substituted by other polar or 
small amino acids in particular threonine which differs only in that it has a methyl group in 
place of a hydrogen group found in serine [37]. These genetic variations can change an indi‐
vidual’s susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of 
certain drugs but GST mu protein in active sites not present the classical Asp‐His‐Ser therefore 
not would find affected by this change of amino acid mu GST biological activity.
5. Conclusion
GST activity has this great potential importance as it might contribute to generating the phe‐
nomenon of resistance to TCBZ. These results contribute to the understanding not only of this 
Figure 6. Amino acid alignments of GST mu isoenzyme of Fasciola hepatica susceptible and resistant to TCBZ. Light 
shading indicates change of one amino acid at position 143 in the TCBZ resistant strain.
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metabolic pathway but also of the mechanism of resistance to TCBZ in F. hepatica. The results 
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